1. Volume 67, Issue 6, Pages 2325-2329 (June 2005)
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy 
Steen Andersen, Frans A. van Nieuwenhoven, Lise Tarnow, Peter Rossing, Kasper Rossing, Lotte Wieten, Roel Goldschmeding, Hans- Henrik Parving 
Kidney International 
Volume 67, Issue 6, Pages (June 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1
Urinary connective tissue growth factor (CTGF) excretion in hypertensive type 1 diabetic patients with diabetic nephropathy during Losartan treatment. All P < 0.05 vs. baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
Scatterplots of (A) changes in albuminuria vs. changes in urinary connective tissue growth factor (CTGF)(r = 0.54,P < 0.01)and (B) rate of decline in glomerular filtration rate (GFR) vs. changes in urinary CTGF(r = 0.23, P = 0.05).
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions